Mariela Granero Farias
Overview
Explore the profile of Mariela Granero Farias including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bock P, Monteiro R, Maraschin C, Alegretti A, Farias M, Spagnol F, et al.
Arch Endocrinol Metab
. 2025 Jan;
68(Spec Issue):e230499.
PMID: 39876965
Objective: To determine circulating endothelial progenitor cells (EPC) counts and levels of inflammatory markers in individuals with and without type 1 diabetes mellitus (T1DM) in response to an intense aerobic...
2.
Farias M, Dos Santos C, Aparecida Paz A, Daudt L
Transpl Immunol
. 2024 Jan;
83:102002.
PMID: 38286299
Introduction: Hematopoietic Stem Cell Transplant (HSCT) is currently an important curative treatment for many patients with malignant and non-malignant diseases. Graft versus host disease (GVHD) represents a major complication in...
3.
de Freitas C, Farias M
J Immunol Methods
. 2023 Dec;
524:113589.
PMID: 38043698
Sepsis is a highly fatal disease that affects millions of people worldwide every year. Currently, the diagnosis of sepsis is made by identifying at least two symptoms of systemic inflammatory...
4.
Cecconello D, Spagnol F, Alegretti A, Pilger D, Farias M
Hematol Transfus Cell Ther
. 2023 Aug;
46 Suppl 5:S136-S142.
PMID: 37652805
Introduction And Objective: Flow Cytometry (FC) is one of the techniques, which allows the identification and characterization of platelets. The detection of absent or reduced expression of the glycoproteins is...
5.
Brum da Silva Nunes V, Dias C, Scholl J, SantAna A, de Fraga Dias A, Farias M, et al.
Discov Oncol
. 2022 Dec;
13(1):143.
PMID: 36581667
Purpose: Although risk-stratified chemotherapy regimens improve B-cell acute lymphoblastic leukemia (B-ALL) clinical outcome, relapse occurs in a significant number of cases. The identification of new therapeutic targets as well as...
6.
Machado Arlindo De Mattos E, Farias M, Burin M, Alegretti A
Hematol Transfus Cell Ther
. 2022 Dec;
46(3):311-315.
PMID: 36494271
No abstract available.
7.
Menegotto P, Farias M, Spagnol F, Siebert M, Filippi-Chiela E, Alegretti A, et al.
Arch Pathol Lab Med
. 2022 Sep;
147(6):701-709.
PMID: 36161791
Context.—: Nucleophosmin 1 (NPM1) mutations affect 20% to 30% of all acute myeloid leukemia (AML) patients; several methods are employed to analyze NPM1 mutations, each of them with its advantages...
8.
Brum da Silva Nunes V, Dias C, De Bastiani M, Farias M, Spagnol F, Alegretti A, et al.
Purinergic Signal
. 2022 Mar;
18(2):211-222.
PMID: 35235138
The risk stratification of B-acute lymphoblastic leukemia (B-ALL) is based on clinical and biological factors. However, B-ALL has significant biological and clinical heterogeneity and 50% of B-ALL patients do not...
9.
Farias M, de Mello Vicente B, Habigzang M, Hirakata V, da Silva P, Aparecida Paz A, et al.
Transpl Immunol
. 2022 Jan;
71:101543.
PMID: 35093504
Introduction: Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) can be used as an alternative procedure in the absence of HLA-compatible donors. The use of high doses of cyclophosphamide after infusion improves...
10.
Furlanetto G, Spagnol F, Alegretti A, Farias M, Soares V, Daudt L, et al.
J Immunol Methods
. 2021 Sep;
498:113135.
PMID: 34478717
In recent years, there has been an expansion in the use of flow cytometry (FC) immunophenotyping in the diagnosis and monitoring of childhood solid neoplasms. Neuroblastoma (NB), in turn, is...